N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography

被引:27
|
作者
Schmidt, Paul
Pang, Dorothy
Nykamp, Diane
Knowlton, Gregory
Jia, Haomiao
机构
[1] St Josephs Hosp, Dept Nephrol, Atlanta, GA 30342 USA
[2] Mercer Univ, Coll Pharm & Hlth Sci, Dept Clin & Adm Sci, Atlanta, GA USA
[3] Mercer Univ, Sch Med, Atlanta, GA USA
关键词
N-acetylcysteine; radiocontrast-induced nephropathy; sodium bicarbonate;
D O I
10.1345/aph.1H354
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Radiocontrast-induced nephropathy (RCIN) is thought to be caused by renal ischemia and direct toxic effects on renal tubular cells brought on by contrast media. The combination of N-acetylcysteine (NAC) and hydration fluids (NaCl 0.9% or 0.45%) has been shown to reduce these deleterious effects and is commonly given prior to coronary angiography. The use of bicarbonate as the hydration anion has been shown to confer additional RCIN protection compared with that of saline. However, limited data are available regarding whether sodium bicarbonate hydration, proven to be beneficial alone, can further improve outcomes when given with NAC. OBJECTIVE: To compare the incidence of RCIN in patients undergoing coronary angiography from January 2002 to December 2005. Data were collected through electronic chart reviews. RESULTS: Forty-seven patients received NAC and sodium bicarbonate for hydration and 49 received NAC and standard hydration. Baseline characteristics between the 2 groups were similar. All patients received at least one 600 mg oral dose of NAC before before angiography was performed. RCIN was defined as impairment of renal function occurring within 72 hours of administering contrast media, indicated by an absolute increase in the serum creatinine level of 0.5 mg/dL or more. A total of 12.2% of the patients receiving NAC and standard hydration developed RCIN, versus 14.9% of the patients in the NAC and sodium bicarbonate group (p = 0.713). CONCLUSIONS: The addition of sodium bicarbonate to NAC does not appear to confer additional protection against the development of RCIN. Prospective, randomized, placebo-controlled trials are warranted to definitely determine how this combination compares with NAC and standard hydration in preventing RCIN.
引用
收藏
页码:46 / 50
页数:5
相关论文
共 50 条
  • [31] Preventive effect of N-acetylcysteine on contrast-induced nephropathy following coronary angiography and angioplasty
    Kamiyama, Naoko
    Ogawa, Ryuichi
    Hamada, Hiroko
    Ohno, Tetsuo
    Asano, Ryuta
    Umemura, Jun
    Yoshida, Hisahiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2008, 128 (09): : 1333 - 1339
  • [32] N-acetylcysteine for the prevention of radiocontrast induced nephropathy: A meta-analysis of prospective controlled trials
    Kshirsagar, AV
    Poole, C
    Mottl, A
    Shoham, D
    Franceschini, N
    Tudor, G
    Agrawal, M
    Denu-Ciocca, C
    Ohman, EM
    Finn, WF
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (03): : 761 - 769
  • [33] N-acetylcysteine and contrast nephropathy
    Birck, R
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (6-7) : 409 - 409
  • [34] Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy
    Richter, Sara K.
    Crannage, Andrew J.
    PHARMACOTHERAPY, 2013, 33 (10): : E182 - E183
  • [35] Is N-acetylcysteine effective for prevention of contrast-induced nephropathy?
    Staniloae, C.
    Natarajan, M.
    Doucet, S.
    Sharma, S. K.
    Katholi, R. E.
    Solomon, R. J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 317 - 317
  • [36] Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy
    Richter, Sara K.
    Crannage, Andrew J.
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2015, 5 (03):
  • [37] Sodium bicarbonate plus N-acetylcysteine in the prevention of contrast agent-induced nephropathy in the setting of primary percutaneous coronary intervention
    Leone, A. M.
    De Caterina, A.
    Aurelio, A.
    Sciahbasi, A.
    Lioy, E.
    Trani, C.
    Burzotta, F.
    Porto, I.
    Rebuzzi, A. G.
    Crea, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0F) : F87 - F87
  • [38] Sodium Bicarbonate versus Sodium Chloride and Oral N-Acetylcysteine for the Prevention of Contrast-Induced Nephropathy in Advanced Chronic Kidney Disease
    Shavit, Linda
    Korenfeld, Roman
    Lifschitz, Meyer
    Butnaru, Ady
    Slotki, Itzchak
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2009, 22 (06) : 556 - 563
  • [39] N-acetylcysteine and contrast-induced nephropathy
    Wolak, Arik
    Cafri, Carlos
    Zahger, Doron
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1498 - 1498
  • [40] N-Acetylcysteine and Contrast-Induced Nephropathy
    Yayla, Cagri
    Yayla, Kadriye Gayretli
    Unal, Sefa
    Acar, Burak
    Akboga, Mehmet Kadri
    Demirtas, Koray
    ANGIOLOGY, 2018, 69 (01) : 85 - 85